Vidarabine FDA Link

A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.

Also Known As:

Vira-A; Ara A; 9-beta-Arabinofuranosyladenine; 9-beta-D-Arabinofuranosyladenine; alpha-Ara A; alpha-D-Arabinofuranosyladenine; beta-Ara A; 9 beta Arabinofuranosyladenine; 9 beta D Arabinofuranosyladenine; Arabinoside, Adenine; Vira A; ViraA; alpha Ara A; alpha D Arabinofuranosyladenine; beta Ara A; Adenine Arabinoside; Ara-A; Arabinofuranosyladenine; Arabinosyladenine; 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-

Pharmalogical Action Categories:

Antimetabolites
Antiviral Agents

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        Vidarabine: 560
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - Vidarabine: 560
  - Arabinonucleosides: 1
    - Vidarabine: 560

9- (5'- (2- oxo- 1,3,2- dioxaphosphorinan- 2- yl)- beta- arabinosyl)adenine

Bio-Agent Context: Research Results